Ultrasound-based deep learning radiomics in the assessment of pathological complete response to neoadjuvant chemotherapy in locally advanced breast cancer

被引:111
|
作者
Jiang, Meng [1 ]
Li, Chang-Li [2 ]
Luo, Xiao-Mao [3 ,4 ]
Chuan, Zhi-Rui [3 ,4 ]
Lv, Wen-Zhi [5 ]
Li, Xu [6 ]
Cui, Xin-Wu [1 ]
Dietrich, Christoph F. [7 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Med Ultrasound, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China
[2] Hubei Prov Hosp Integrated Chinese & Western Med, Dept Geratol, 11 Lingjiaohu Ave, Wuhan 430015, Peoples R China
[3] Kunming Med Univ, Dept Med Ultrasound, Yunnan Canc Hosp, Kunming 650118, Yunnan, Peoples R China
[4] Kunming Med Univ, Affiliated Hosp 3, Kunming 650118, Yunnan, Peoples R China
[5] Julei Technol, Dept Artificial Intelligence, Wuhan 430030, Peoples R China
[6] South Cent Univ Nationalities, Sch Biomed Engn, 182 Minyuan Rd, Wuhan 430074, Peoples R China
[7] Hirslanden Clin, Dept Internal Med, Schanzlihalde 11, CH-3013 Bern, Switzerland
基金
中国博士后科学基金;
关键词
PPathological complete response; DDeep learning; RRadiomic nomogram; Locally advanced breast cancer; PREDICTION; ESTROGEN; NOMOGRAM; MRI;
D O I
10.1016/j.ejca.2021.01.028
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The aim of the study was to develop and validate a deep learning radiomic nomogram (DLRN) for preoperatively assessing breast cancer pathological complete response (pCR) after neoadjuvant chemotherapy (NAC) based on the pre- and post-treatment ultrasound. Methods: Patients with locally advanced breast cancer (LABC) proved by biopsy who proceeded to undergo preoperative NAC were enrolled from hospital #1 (training cohort, 356 cases) and hospital #2 (independent external validation cohort, 236 cases). Deep learning and handcrafted radiomic features reflecting the phenotypes of the pre- treatment (radiomic signature [RS] 1) and post-treatment tumour (RS2) were extracted. The minimum redundancy maximum relevance algorithm and the least absolute shrinkage and selection operator regression were used for feature selection and RS construction. A DLRN was then developed based on the RSs and independent clinicopathological risk factors. The performance of the model was assessed with regard to calibration, discrimination and clinical usefulness. Results: The DLRN predicted the pCR status with accuracy, yielded an area under the receiver operator characteristic curve of 0.94 (95% confidence interval, 0.91-0.97) in the validation cohort, with good calibration. The DLRN outperformed the clinical model and single RS within both cohorts (P < 0.05, as per the DeLong test) and performed better than two experts' prediction of pCR (both P < 0.01 for comparison of total accuracy). Besides, prediction within the hormone receptor-positive/human epidermal growth factor receptor 2 (HER2)-negative, HER2+ and triple-negative subgroups also achieved good discrimination performance, with an AUC of 0.90, 0.95 and 0.93, respectively, in the external validation cohort. Decision curve analysis confirmed that the model was clinically useful. Conclusion: A deep learning-based radiomic nomogram had good predictive value for pCR in LABC, which could provide valuable information for individual treatment. (C) 2021 Elsevier Ltd. All rights reserved.
引用
收藏
页码:95 / 105
页数:11
相关论文
共 50 条
  • [1] An ultrasound-based nomogram model in the assessment of pathological complete response of neoadjuvant chemotherapy in breast cancer
    Liu, Jinhui
    Leng, Xiaoling
    Liu, Wen
    Ma, Yuexin
    Qiu, Lin
    Zumureti, Tuerhong
    Zhang, Haijian
    Mila, Yeerlan
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [2] Pretreatment ultrasound-based deep learning radiomics model for the early prediction of pathologic response to neoadjuvant chemotherapy in breast cancer
    Yu, Fei-Hong
    Miao, Shu-Mei
    Li, Cui-Ying
    Hang, Jing
    Deng, Jing
    Ye, Xin-Hua
    Liu, Yun
    EUROPEAN RADIOLOGY, 2023, 33 (08) : 5634 - 5644
  • [3] Pretreatment ultrasound-based deep learning radiomics model for the early prediction of pathologic response to neoadjuvant chemotherapy in breast cancer
    Fei-Hong Yu
    Shu-Mei Miao
    Cui-Ying Li
    Jing Hang
    Jing Deng
    Xin-Hua Ye
    Yun Liu
    European Radiology, 2023, 33 : 5634 - 5644
  • [4] Are there predictive factors for a pathological complete response after neoadjuvant chemotherapy in locally advanced breast cancer?
    Warm, M.
    Cramer, E-M
    Bosse, K.
    Moers, C.
    Thomas, A.
    Mallmann, P.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S154 - S154
  • [5] Clinical, radiological and pathological assessment of response to neoadjuvant chemotherapy in patients with locally advanced breast cancer
    Srivastava, A
    Bosu, NK
    Coshic, O
    Kumar, A
    Dawar, R
    Bandhu, S
    Goyal, A
    BRITISH JOURNAL OF CANCER, 2001, 85 : 49 - 49
  • [6] Neoadjuvant chemotherapy in locally advanced breast cancer: Clinicopathological characteristics and correlation with pathological complete response.
    Choudhary, Priyanshu
    Gogia, Ajay
    Deo, Svs
    Mathur, Sandeep
    Sharma, Dayanand
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [7] The Role of Postmastectomy Radiotherapy in Locally Advanced Breast Cancer After Pathological Complete Response to Neoadjuvant Chemotherapy
    Flores-Balcazar, Christian Haydee
    Castro-Alonso, Francisco Javier
    Hernandez-Barragan, Tania Patricia
    Delgado-de la Mora, Jesus
    Daidone, Antonino
    Trejo-Duran, Guadalupe Elizabeth
    ONCOLOGY-NEW YORK, 2021, 35 (03): : 139 - 143
  • [8] Radiomics Analysis for Evaluation of Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
    Liu, Zhenyu
    Zhang, Xiao-Yan
    Shi, Yan-Jie
    Wang, Lin
    Zhu, Hai-Tao
    Tang, Zhenchao
    Wang, Shuo
    Li, Xiao-Ting
    Tian, Jie
    Sun, Ying-Shi
    CLINICAL CANCER RESEARCH, 2017, 23 (23) : 7253 - 7262
  • [9] Deep Learning Model for Predicting the Pathological Complete Response to Neoadjuvant Chemoradiotherapy of Locally Advanced Rectal Cancer
    Lou, Xiaoying
    Zhou, Niyun
    Feng, Lili
    Li, Zhenhui
    Fang, Yuqi
    Fan, Xinjuan
    Liu, Hailing
    Yao, Jianhua
    Huang, Yan
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 489 - 490
  • [10] Deep Learning Model for Predicting the Pathological Complete Response to Neoadjuvant Chemoradiotherapy of Locally Advanced Rectal Cancer
    Lou, Xiaoying
    Zhou, Niyun
    Feng, Lili
    Li, Zhenhui
    Fang, Yuqi
    Fan, Xinjuan
    Liu, Hailing
    Yao, Jianhua
    Huang, Yan
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 489 - 490